Practice Management News

Losing the constitutional right to abortion is associated with a 10% increase in mental distress prevalence among women of reproductive age, researchers reported in JAMA Network Open.

Purdue Pharma announced it plans to provide up to $9 million in additional financial support for a low-cost over-the-counter intranasal naloxone spray.

HHS announced it has awarded $1 million 1-year Certified Community Behavioral Health Clinic planning grants to 15 states through the Substance Abuse and Mental Health Services Administration.

The AMA and 118 other leading medical societies recently announced that they have united in support of CMS’ prior authorization reform proposal.

A biopharmaceutical company has announced positive topline results from its phase 2, randomized, open-label trial of evenamide as an add-on to antipsychotic medication in those with moderate to severe treatment-resistant schizophrenia.

Private equity has had a long involvement with and continues to stay active in the business of health care.

For the first time, a study found a link between the COVID-19 pandemic’s impact on family finances and children’s mental health, researchers reported.

The University of Nebraska Medical Center and Ananda Scientific have enrolled the first patient in a phase 2 clinical trial of an investigational cannabidiol drug for PTSD, according to a press release.

An FDA mandate limiting acetaminophen in medications combining acetaminophen and opioids was associated with a reduction in serious liver injuries, a recent study in JAMA found.

Combining motivational interviews with cognitive behavioral therapy improved negative symptoms of schizophrenia compared with mindfulness sessions, according to findings published in The American Journal of Psychiatry.